Patents by Inventor Josep Terradas

Josep Terradas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Particle size stabilization process
    Patent number: 10888500
    Abstract: The present invention provides a new process for stabilizing the particle size of micronized glycopyrronium salt (such as glycopyrronium bromide) which yields a micronized product exhibiting improved chemical and polymorphic stability even after prolonged storage. The invention also relates to compositions comprising said stabilized glycopyrronium salt (such as glycopyrronium bromide) and to dry powder inhaler devices and capsules or blisters comprising the stabilized glycopyrronium salt (such as glycopyrronium bromide). The glycopyrronium salt (such as glycopyrronium bromide) or compositions of the invention may be used as a medicament, for instance in the treatment of asthma, chronic obstructive pulmonary disease or cystic fibrosis or related diseases.
    Type: Grant
    Filed: July 25, 2017
    Date of Patent: January 12, 2021
    Assignee: INKE, S.A.
    Inventors: Josep Terradas Camins, Josep Maria Carulla Oliver, Silvia Donnici Garcia, David Gomez Lamarca, Maria Jose Martinez Velon, Emma Recio Soler
  • PARTICLE SIZE STABILIZATION PROCESS
    Publication number: 20190175451
    Abstract: The present invention provides a new process for stabilizing the particle size of micronized glycopyrronium salt (such as glycopyrronium bromide) which yields a micronized product exhibiting improved chemical and polymorphic stability even after prolonged storage. The invention also relates to compositions comprising said stabilized glycopyrronium salt (such as glycopyrronium bromide) and to dry powder inhaler devices and capsules or blisters comprising the stabilized glycopyrronium salt (such as glycopyrronium bromide). The glycopyrronium salt (such as glycopyrronium bromide) or compositions of the invention may be used as a medicament, for instance in the treatment of asthma, chronic obstructive pulmonary disease or cystic fibrosis or related diseases.
    Type: Application
    Filed: July 25, 2017
    Publication date: June 13, 2019
    Inventors: Josep Terradas Camins, Josep Maria Carulla Oliver, Silvia Donnici Garcia, David Gomez Lamarca, Maria Jose Martinez Velon, Emma Recio Soler
  • Stable micronised monoclin form of asenapine maleate and its synthesis
    Patent number: 9505771
    Abstract: A stable micronized monoclinic form of asenapine maleate is described, which comprises 5% by weight or less of orthorhombic form or any other crystalline form of asenapine maleate, wherein the asenapine maleate has a particle size distribution characterized by a d90 equal to or below 40 ?m. Processes for preparing the stable micronized monoclinic form of asenapine maleate are also described. Formula (I).
    Type: Grant
    Filed: May 18, 2012
    Date of Patent: November 29, 2016
    Assignee: Laboratories Lesvi S.L.
    Inventors: Agusti Bertran, Josep Terradas
  • STABLE MICRONISED MONOCLINIC FORM OF ASENAPINE MALEATE AND ITS SYNTHESIS
    Publication number: 20140142158
    Abstract: A stable micronised monoclinic form of asenapine maleate is described, which comprises 5% by weight or less of orthorhombic form or any other crystalline form of asenapine maleate, wherein the asenapine maleate has a particle size distribution characterised by a d90 equal to or below 40 ?m. Processes for preparing the stable micronised monoclinic form of asenapine maleate are also described. Formula (I).
    Type: Application
    Filed: May 18, 2012
    Publication date: May 22, 2014
    Applicant: LABORATORIOS LESVI S.L.
    Inventors: Agustì Bertran, Josep Terradas